Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers

Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers

Background: Vaccines for SARS-CoV-2 have been critical for preventing disease. Previous research showed patients with diabetes have impaired immunity. This study aimed to determine the immunity to coronavirus after CoronaVac by comparing patients with type 2 diabetes (T2D) and healthcare workers (HC...

Celý popis

Podrobná bibliografie
Hlavní autoři: Bothamai Dechates, Thachanun Porntharukchareon, Supamas Sirisreetreerux, Phonthip Therawit, Supanat Worawitchawong, Gaidganok Sornsamdang, Kamonwan Soonklang, Kriangkrai Tawinprai
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2023-03-01
Edice:Vaccines
Témata:
diabetes mellitus
CoronaVac
Sinovac
anti-RBD
immunoglobulin
On-line přístup:https://www.mdpi.com/2076-393X/11/3/684

Internet

https://www.mdpi.com/2076-393X/11/3/684

Podobné jednotky